Literature DB >> 31408723

Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms.

Peter Valent1, Irina Sadovnik2, Gregor Eisenwort2, Harald Herrmann3, Karin Bauer2, Niklas Mueller4, Wolfgang R Sperr2, Daniel Wicklein5, Udo Schumacher5.   

Abstract

The development of a myeloid neoplasm is a step-wise process that originates from leukemic stem cells (LSC) and includes pre-leukemic stages, overt leukemia and a drug-resistant terminal phase. Organ-invasion may occur in any stage, but is usually associated with advanced disease and a poor prognosis. Sometimes, extra-medullary organ invasion shows a metastasis-like or even sarcoma-like destructive growth of neoplastic cells in local tissue sites. Examples are myeloid sarcoma, mast cell sarcoma and localized blast phase of chronic myeloid leukemia. So far, little is known about mechanisms underlying re-distribution and extramedullary dissemination of LSC in myeloid neoplasms. In this article, we discuss mechanisms through which LSC can mobilize out of the bone marrow niche, can transmigrate from the blood stream into extramedullary organs, can invade local tissue sites and can potentially create or support the formation of local stem cell niches. In addition, we discuss strategies to interfere with LSC expansion and organ invasion by targeted drug therapies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extramedullary myelopoiesis; Leukemia; Mast cell sarcoma; Myeloid sarcoma; Neoplastic stem cells; Stem cell invasion; Stem cell niche

Mesh:

Substances:

Year:  2019        PMID: 31408723      PMCID: PMC7115853          DOI: 10.1016/j.semcancer.2019.07.025

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  164 in total

Review 1.  Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic.

Authors:  J L Liesveld; J F Dipersio; C N Abboud
Journal:  Leuk Lymphoma       Date:  1994-06

2.  Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells.

Authors:  G H Schernthaner; J H Jordan; M Ghannadan; H Agis; D Bevec; R Nuñez; L Escribano; O Majdic; M Willheim; C Worda; D Printz; G Fritsch; K Lechner; P Valent
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

3.  JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms.

Authors:  Chi Hua Sarah Lin; Kenneth Kaushansky; Huichun Zhan
Journal:  Blood Cells Mol Dis       Date:  2016-11-04       Impact factor: 3.039

4.  Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts.

Authors:  M De Waele; W Renmans; K Jochmans; R Schots; P Lacor; F Trullemans; J Otten; N Balduck; K Vander Gucht; B Van Camp; I Van Riet
Journal:  Eur J Haematol       Date:  1999-09       Impact factor: 2.997

5.  Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.

Authors:  David C Taussig; Farideh Miraki-Moud; Fernando Anjos-Afonso; Daniel J Pearce; Kirsty Allen; Christopher Ridler; Debra Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

Review 6.  Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence.

Authors:  Armin Rashidi; John F DiPersio
Journal:  Ther Adv Hematol       Date:  2016-02

7.  Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia.

Authors:  Norbert Vey; Jacques Delaunay; Giovanni Martinelli; Walter Fiedler; Emmanuel Raffoux; Thomas Prebet; Carlos Gomez-Roca; Cristina Papayannidis; Maxim Kebenko; Peter Paschka; Randolph Christen; Ernesto Guarin; Ann-Marie Bröske; Monika Baehner; Michael Brewster; Antje-Christine Walz; Francesca Michielin; Valeria Runza; Valerie Meresse; Christian Recher
Journal:  Oncotarget       Date:  2016-05-31

Review 8.  Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.

Authors:  Peter Valent; Wolfgang Kern; Gregor Hoermann; Jelena D Milosevic Feenstra; Karl Sotlar; Michael Pfeilstöcker; Ulrich Germing; Wolfgang R Sperr; Andreas Reiter; Dominik Wolf; Michel Arock; Torsten Haferlach; Hans-Peter Horny
Journal:  Int J Mol Sci       Date:  2019-02-12       Impact factor: 5.923

Review 9.  Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia.

Authors:  M Ryan Corces; Howard Y Chang; Ravindra Majeti
Journal:  Front Oncol       Date:  2017-11-06       Impact factor: 6.244

10.  Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

Authors:  Irina Sadovnik; Andrea Hoelbl-Kovacic; Harald Herrmann; Gregor Eisenwort; Sabine Cerny-Reiterer; Wolfgang Warsch; Gregor Hoermann; Georg Greiner; Katharina Blatt; Barbara Peter; Gabriele Stefanzl; Daniela Berger; Martin Bilban; Susanne Herndlhofer; Heinz Sill; Wolfgang R Sperr; Berthold Streubel; Christine Mannhalter; Tessa L Holyoake; Veronika Sexl; Peter Valent
Journal:  Clin Cancer Res       Date:  2015-11-25       Impact factor: 12.531

View more
  4 in total

1.  PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.

Authors:  Yüksel Filik; Karin Bauer; Emir Hadzijusufovic; Patrick Haider; Georg Greiner; Nadine Witzeneder; Gregor Hoermann; Philipp J Hohensinner; Karoline V Gleixner; Johann Wojta; Wolfgang R Sperr; Peter Valent
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  Microarrayed human bone marrow organoids for modeling blood stem cell dynamics.

Authors:  Sonja Giger; Moritz Hofer; Marijana Miljkovic-Licina; Sylke Hoehnel; Nathalie Brandenberg; Romain Guiet; Martin Ehrbar; Esther Kleiner; Katharina Gegenschatz-Schmid; Thomas Matthes; Matthias P Lutolf
Journal:  APL Bioeng       Date:  2022-07-08

Review 3.  Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias.

Authors:  Xingjian Zhai; Xiaoyan Jiang
Journal:  Biomedicines       Date:  2022-07-30

4.  Myeloid sarcoma with ulnar nerve entrapment: A case report.

Authors:  Da-Peng Li; Chao-Zong Liu; Mortimer Jeremy; Xin Li; Jin-Chao Wang; Swastina Nath Varma; Ting-Ting Gai; Wei-Qi Tian; Qi Zou; Yan-Mian Wei; Hao-Yu Wang; Chang-Jiang Long; Yu Zhou
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.